LEXINGTON, Mass.--(BUSINESS WIRE)-- Agenus Inc., a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus ...
LEXINGTON, Mass., January 15, 2026--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results